Results 291 to 300 of about 256,813 (405)

Graft—Versus—Breast Cancer Effect by Allogeneic Hematopoietic Stem-Cell Transplantation: A Possible New Frontier [PDF]

, 2004
Naoto T. Ueno, Elizabeth J. Shpall, Richard E. Champlin, Roy B. Jones   +3 more
openalex   +1 more source

Diabetic stem-cell mobilopathy [PDF]

, 2011
DiPersio, John F
core   +2 more sources

Ratifying the efficacy and safety of intensive induction chemotherapy for acute myeloid leukaemia by the Australasian Leukaemia & Lymphoma Group consensus approach

Internal Medicine Journal, EarlyView.
Abstract Background After pharmaceutical benefits scheme approval of midostaurin for fms‐like tyrosine kinase 3 (FLT3)‐mutated acute myeloid leukaemia (AML) in 2018, the Australasian Leukaemia & Lymphoma Group (ALLG) proposed a consensus approach to AML induction with 7+3 chemotherapy (7 days of infusional cytarabine with three doses of anthracycline ...
Aditya Tedjaseputra, Amanda Tey, Anastasios Nalpantidis, George Grigoriadis, Shaun Fleming, Shahla Vilcassim, Pasquale L. Fedele, Michael Sze Yuan Low, Paul Yeh, Michael Gilbertson, Ashwini Bennett, Gareth P. Gregory, Danielle Oh, Donna Gairns, Zane Kaplan, Sanjeev D. Chunilal, Susan Brown, Stephen Opat, Chong C. Chua, Jake Shortt   +19 more
wiley   +1 more source

Denileukin diftitox (ONTAK) as targeted therapy against steroid refractory graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT) [PDF]

, 2004
Vincent T. Ho, Ephraim P. Hochberg, David Zahrieh, Corey Cutler, Steven Steckel, Seok-Joo Lee, Edwin P. Alyea, Jerome Ritz, Robert J. Soiffer, Joseph H. Antin   +9 more
openalex   +1 more source

Dendritic cells in rejection and acceptance of solid organ allografts [PDF]

, 1999
Demetris, AJ, Fung, JJ, Murase, N, Starzl, TE   +3 more
core  

Connective tissue disease‐associated interstitial lung disease: an approach to treatment amidst an expanding evidence base

Internal Medicine Journal, EarlyView.
ABSTRACT Connective tissue disease‐associated interstitial lung disease (CTD‐ILD) comprises a heterogenous group of conditions characterised by immune‐mediated fibro‐inflammatory pulmonary injury. Although the disease course is variable, CTD‐ILD can progress to respiratory failure and thus has a profound impact on morbidity and mortality.
Michael Hong, Elizabeth Veitch, Sandhya Limaye   +2 more
wiley   +1 more source

Genital graft versus host disease in women after allogeneic hematopoietic stem cell transplantation - a single center experience. [PDF]

Ann Hematol
Wilk Goldsher Y, Cohen Sacher B, Cohen M, Yeshurun M, Sabah G, Eitan R, Krissi H.   +6 more
europepmc   +1 more source

Infections after Allogeneic Hematopoietic Stem Cell Transplantation with a Nonmyeloablative Conditioning Regimen. [PDF]

, 2004
Pascale Frère, Frédéric Baron, C Bonnet, Kaoutar Hafraoui, Maguy Pereira, Évelyne Willems, Georges Fillet, Yves Béguin   +7 more
openalex   +1 more source

Outcomes of allogeneic haemopoietic transplant for chronic lymphocytic leukaemia in the modern era

Internal Medicine Journal, EarlyView.
Abstract Background Allogeneic haemopoietic stem cell transplantation (HSCT) is an effective therapy with curative potential for patients with high‐risk or relapsed/refractory chronic lymphocytic leukaemia (CLL). There are limited data on the use and outcomes of HSCT in the modern era of CLL treatment.
Luani Barge, Steven Tran, Glen Kennedy, David Ritchie, David Gottlieb, Sam Milliken, Andrew Spencer, Duncan Purtill, Travis Perera, Richard Doocey, Stephen Larsen, Andrew Butler, Peter Bardy, Matthew Greenwood, Simon Durrant, Cameron Curley, Caroline Stewart, Constantine Tam, Shalini Balendran, Pietro R. Di Ciaccio, Sushrut Patil, Min‐Hi Han, Nada Hamad   +22 more
wiley   +1 more source

Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With a Germline DDX41 Mutation. [PDF]

Case Rep Hematol
Yoshida S, Semba Y, Takashima S, Kadowaki M, Takase K, Maeda T, Akashi K, Iwasaki H.   +7 more
europepmc   +1 more source